Company Overview of IDD Therapeutics Ltd
IDD Therapeutics Ltd. engages in designing, developing, and commercializing pharmaceuticals for cancer therapy. It develops MDL-1100, a synthetic small molecule for the treatment of solid tumors and metastasis. The company was founded in 2010 and is based in Nazareth, Israel.
Nazareth Industrial Zone
Founded in 2010
972 4 609 8600
972 4 656 4129
Key Executives for IDD Therapeutics Ltd
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|AIT Therapeutics, Inc.||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact IDD Therapeutics Ltd, please visit www.idd-therapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.